These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8714584)

  • 1. Towards gene therapy of hemoglobinopathies.
    Beuzard Y
    Semin Hematol; 1996 Jan; 33(1):43-52. PubMed ID: 8714584
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G; Malik P
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
    Bank A
    Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future prospects for treatment of hemoglobinopathies.
    Stamatoyannopoulos JA
    West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for the hemoglobin disorders.
    Persons DA; Nienhuis AW
    Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease.
    Sadelain M
    Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924
    [No Abstract]   [Full Text] [Related]  

  • 9. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
    Lebensburger J; Persons DA
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy. Gene gemisch cures sickle cell in mice.
    Marshall E
    Science; 2001 Dec; 294(5550):2268. PubMed ID: 11743172
    [No Abstract]   [Full Text] [Related]  

  • 13. A New Era for Hemoglobinopathies: More Than One Curative Option.
    Psatha N; Papayanni PG; Yannaki E
    Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T; Tubb J; Emery DW
    Blood Cells Mol Dis; 2006; 37(1):1-7. PubMed ID: 16814578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-based therapeutic interventions for β-type hemoglobinopathies.
    Karamperis K; Tsoumpeli MT; Kounelis F; Koromina M; Mitropoulou C; Moutinho C; Patrinos GP
    Hum Genomics; 2021 Jun; 15(1):32. PubMed ID: 34090531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
    Payen E; Leboulch P
    Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing.
    Rivella S; Sadelain M
    Semin Hematol; 1998 Apr; 35(2):112-25. PubMed ID: 9565154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythrocyte transfusions in hemoglobinopathies: indications].
    Galacteros F
    Transfus Clin Biol; 1994; 1(1):15-7. PubMed ID: 8186847
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction.
    Perumbeti A; Malik P
    Ann N Y Acad Sci; 2010 Aug; 1202():36-44. PubMed ID: 20712770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.